点击次数：

论文类型：期刊论文

发表时间：2011-01-15

发表刊物：BIOORGANIC & MEDICINAL CHEMISTRY

收录刊物：Scopus、SCIE

卷号：19

期号：2

页面范围：961-967

ISSN号：0968-0896

关键字：5-Aromatic substituted naphthalimide; Amonafide; Suzuki reaction; DNA-binding

摘要：Amonafide is a naphthalimide derivative with antitumor activity and has failed to enter clinical phase III, because of its high-variable and unpredictable toxicity. In order to develop selective, efficient, and safe drugs, applying the 'nonfused' aromatic system strategy, a series of 5-non-amino aromatic substituted naphthalimides as replacement for amonafide were designed and were synthesized from naphthalic anhydride by three steps including bromination, amination, and Pd(PPh3)(4) catalyzed Suzuki reaction. These new naphthalimide derivatives, except 4b, not only exhibited better activity than amonafide against HeLa and P388D1 cell lines in vitro under the same experimental conditions, but also could avoid the side effect of amonafide due to their structure, which lacks an easy acetylated arylamine at the 5 position. The DNA-binding behavior of the naphthalimide derivatives was also investigated, and the results suggested that they bind to DNA via intercalation and 4a and 4g intercalated into DNA in different fashion. (C) 2010 Published by Elsevier Ltd.